QIAGEN NV Valuation
| QIA Stock | EUR 36.05 0.45 1.26% |
At this time, the company appears to be fairly valued. QIAGEN NV owns a latest Real Value of €35.33 per share. The recent price of the company is €36.05. Our model determines the value of QIAGEN NV from analyzing the company fundamentals such as price to book of 3.38 X, and Revenue of 2.14 B as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that QIAGEN NV's price fluctuation is very steady at this time. Calculation of the real value of QIAGEN NV is based on 3 months time horizon. Increasing QIAGEN NV's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the QIAGEN stock is determined by what a typical buyer is willing to pay for full or partial control of QIAGEN NV. Since QIAGEN NV is currently traded on the exchange, buyers and sellers on that exchange determine the market value of QIAGEN Stock. However, QIAGEN NV's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 36.05 | Real 35.33 | Hype 36.05 | Naive 34.97 |
The real value of QIAGEN Stock, also known as its intrinsic value, is the underlying worth of QIAGEN NV Company, which is reflected in its stock price. It is based on QIAGEN NV's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of QIAGEN NV's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of QIAGEN NV helps investors to forecast how QIAGEN stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of QIAGEN NV more accurately as focusing exclusively on QIAGEN NV's fundamentals will not take into account other important factors: QIAGEN NV Total Value Analysis
QIAGEN NV is at this time forecasted to have takeover price of 11.01 B with market capitalization of 10.94 B, debt of 1.47 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the QIAGEN NV fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.01 B | 10.94 B | 1.47 B |
QIAGEN NV Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of QIAGEN indicates not a very effective usage of assets in March.QIAGEN NV Profitability Analysis
The company reported the revenue of 2.14 B. Net Income was 423.21 M with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates QIAGEN NV's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in QIAGEN NV and how it compares across the competition.
About QIAGEN NV Valuation
The stock valuation mechanism determines QIAGEN NV's current worth on a weekly basis. Our valuation model uses a comparative analysis of QIAGEN NV. We calculate exposure to QIAGEN NV's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of QIAGEN NV's related companies.8 Steps to conduct QIAGEN NV's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates QIAGEN NV's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct QIAGEN NV's valuation analysis, follow these 8 steps:- Gather financial information: Obtain QIAGEN NV's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine QIAGEN NV's revenue streams: Identify QIAGEN NV's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research QIAGEN NV's industry and market trends, including the size of the market, growth rate, and competition.
- Establish QIAGEN NV's growth potential: Evaluate QIAGEN NV's management, business model, and growth potential.
- Determine QIAGEN NV's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate QIAGEN NV's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for QIAGEN Stock analysis
When running QIAGEN NV's price analysis, check to measure QIAGEN NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy QIAGEN NV is operating at the current time. Most of QIAGEN NV's value examination focuses on studying past and present price action to predict the probability of QIAGEN NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move QIAGEN NV's price. Additionally, you may evaluate how the addition of QIAGEN NV to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Directory Find actively traded commodities issued by global exchanges |